20595-53-3

Basic information

• Product Name: (E)-3-(3,5-Dichlorophenyl)propenoic acid
• Synonyms: (E)-3-(3,5-Dichlorophenyl)propenoic acid;Trans-3,5-Dichlorocinnamic acid
• CAS NO: 20595-53-3
• Molecular Formula: C₉H₆Cl₂O₂
• Molecular Weight: 217.05
• Mol File: 20595-53-3.mol
• Article Data: 12

Chemical Properties

• Melting Point: 174.5-175.5 °C
• Boiling Point: 364.8°C at 760 mmHg
• Flash Point: 174.4°C
• Appearance: /
• Density: 1.457g/cm³
• Vapor Pressure: 5.81E-06mmHg at 25°C
• Refractive Index: 1.637
• PKA: 4.12±0.10(Predicted)
• CAS DataBase Reference: (E)-3-(3,5-Dichlorophenyl)propenoic acid(CAS DataBase Reference)
• NIST Chemistry Reference: (E)-3-(3,5-Dichlorophenyl)propenoic acid(20595-53-3)
• EPA Substance Registry System: (E)-3-(3,5-Dichlorophenyl)propenoic acid(20595-53-3)

Safety Data

• Hazardous Substances Data: 20595-53-3(Hazardous Substances Data)

Usage

General Description

(E)-3-(3,5-Dichlorophenyl)propenoic acid, also known as (E)-3-(3,5-dichlorophenyl)acrylic acid, is a chemical compound with the molecular formula C9H6Cl2O2. It is a derivative of acrylic acid and is commonly used in the synthesis of various pharmaceuticals and agrochemicals. (E)-3-(3,5-Dichlorophenyl)propenoic acid is also known for its potential anti-inflammatory properties and has been studied for its potential in the treatment of various inflammatory conditions. Additionally, it has been found to exhibit herbicidal activity and has been used in the development of herbicides. (E)-3-(3,5-Dichlorophenyl)propenoic acid is a versatile compound with a range of applications in the pharmaceutical and agricultural industries.

InChI:InChI=1/C9H6Cl2O2/c10-7-3-6(1-2-9(12)13)4-8(11)5-7/h1-5H,(H,12,13)/b2-1+

Upstream product

• 141-82-2 malonic acid 
• 10203-08-4 3,5-dichlorobenzaldehyde 
• 108-24-7 acetic anhydride 
• 110-89-4 piperidine 
• 3032-81-3 3,5-dichloroiodobenzene 
• 695187-25-8 (E)-methyl 3-(3,5-dichlorophenyl)acrylate 

Downstream Products

• 103860-22-6 (E)-ethyl 3-(3,5-dichlorophenyl)acrylate 
• 20595-54-4 3,5-dichloro-cis-cinnamic acid 
• 95333-95-2 3-(3',5'-dichlorophenyl)propanoic acid 
• 448193-94-0 5,7-dichloro-2,3-dihydro-1H-inden-1-one 
• 95333-96-3 3-(3,5-dichlorophenyl)-propanol 
• 95333-97-4 3-(3,5-dichlorophenyl)propan-1-al 
• 101913-07-9 N-<3-(3,5-dichlorophenyl)propyl>aminoacetaldehyde dimethyl acetal 
• 95333-82-7 1-[3-(3,5-dichlorophenyl)propyl]imidazole-2-thione 
• 1613513-39-5 (E)-tert-butyl (2-(1-(3-(3,5-dichlorophenyl)acryloyl)piperidin-4-yl)ethyl)carbamate 
• 1613513-40-8 (E)-1-(4-(2-aminoethyl)piperidin-1-yl)-3-(3,5-dichlorophenyl)prop-2-en-1-one 
• 1613513-41-9 (E)-3-(3,5-dichlorophenyl)-1-(4-(2-(methylamino)ethyl)piperidin-1-yl)prop-2-en-1-one 
• 1613513-38-4 (E)-N-(2-(1-(3-(3,5-dichlorophenyl)acryloyl)piperidin-4-yl)ethyl)-N-methyl-2-oxo-2,3-dihydrooxazole-5-carboxamide 
• 1613513-43-1 (E)-N-(2-(1-(3-(3,5-dichlorophenyl)acryloyl)piperidin-4-yl)ethyl)-2-oxo-2,3-dihydrooxazole-5-carboxamide 
• 1613513-61-3 (E)-N-(1-(3-(3,5-dichlorophenyl)acryloyl)piperidin-4-yl)-4-(1H-1,2,3-triazol-4-yl)butanamide 

Relevant articles and documents

NOVEL SALTS OF SELECTIVE ESTROGEN RECEPTOR DEGRADERS

Provided herein are compounds, salts, crystalline forms, and pharmaceutical compositions that are related to Selective Estrogen Receptor Degraders, as well as methods of preparing the same. Also provided herein are methods of using the compounds, salts, crystalline forms, and pharmaceutical compositions for the treatment of diseases or disorders, such as breast cancer.

Telescopic one-pot condensation-hydroamination strategy for the synthesis of optically pure L-phenylalanines from benzaldehydes

A chemo-enzymatic telescopic approach was designed for the synthesis of L-arylalanines in high yield and optical purity, starting from commercially available and inexpensive substituted benzaldehydes. The method exploits a chemical Knoevenagel–Doebner condensation (optimised to give complete conversions in a short reaction time, employing microwave irradiation) and a biocatalytic phenylalanine ammonia lyase mediated hydroamination (for the stereoselective addition of ammonia). The two reactions can be run sequentially in one pot, bringing together the advantages of chemical and biological catalysis. The preparative applicability was demonstrated with the synthesis of five L-dihalophenylalanines (71–84% yield, 98–99% ee) of relevance as molecular probes, for medicinal chemistry and for the synthesis of pharmaceutical ingredients.

Autotaxin inhibitors

The present invention relates to novel compounds that are autotaxin inhibitors, processes for their preparation, pharmaceutical compositions and medicaments containing them and to their use in diseases and disorders mediated by autotaxin.